Luca Novara

Adaptive mutability of colorectal cancers in response to targeted therapies

Mariangela Russo, Giovanni Crisafulli, Alberto Sogari et al. · Science · 2019 · 446 citations · Full text

Medicine, Cancer Biology, Oncology +17

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · JNCI Journal of the National Cancer Institute · 2017 · 324 citations · Full text

Medicine, Oncology, Pathology +14

Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer

Mariangela Russo, Sandra Misale, Wei Ge et al. · Cancer Discovery · 2015 · 304 citations · Full text

Medicine, Molecular Biology, Oncology +17

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · Annals of Oncology · 2018 · 115 citations · Full text

Medicine, Oncology, Pathology +17

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Giovanni Grignani, Lorenzo D’Ambrosio, Ymera Pignochino et al. · The Lancet Oncology · 2018 · 95 citations · Full text

Medicine, Oncology, Surgery +13